A new report indicates the legal cannabis market in Australia, New Zealand and Oceania region generally is set to boom. Prohibition Partners Oceania Cannabis Report: Second Edition says the region's legal cannabis market is expected to be worth US$1.55 billion by 2024 - that's around AUD $2.45 billion at current...

Australia's Therapeutic Goods Administration (TGA) has provided some updated figures on medical cannabis applications it has approved. The country's Special Access Scheme (SAS) enables suitably authorised health practitioners to access therapeutic goods for a single patient such as medicinal cannabis that are not included in the Australian Register of Therapeutic...

Final harvest numbers from the 2019 hemp growing season in Illinois have been made available by the state's Department of Agriculture (IDOA). For the season last year, IDOA issued 651 hemp grower licenses - but not all put in a crop, with 137 licence holders failing to do so for...

Australia's Zelira Therapeutics (ASX:ZLD) is claiming a win in demonstrating its medicinal cannabis preparation helps people suffering insomnia. Its product, with the less-than-glitzy name of ZLT-101, is ingested sublingually*. The company says a Phase 1b/2a clinical trial of ZLT-101 against insomnia has seen ZLT-101 pass with "flying colours". Undertaken at the...

GW Pharmaceuticals announced yesterday the United States Drug Enforcement Administration (DEA) has determined Epidiolex is no longer subject to the Controlled Substances Act (CSA), effective immediately. Epidiolex is based on cannabidiol (CBD), a non-intoxicating cannabinoid extracted from either industrial hemp or medicinal cannabis. In June 2018, Epidiolex was approved...

Medical cannabis company Helius and post-graduate students at the University of Auckland want to hear from patients and healthcare providers in New Zealand. The initiative is seeking to investigate the needs and challenges related to various patients navigating the process from discovery to consumption of medical cannabis products. "Customer journey mapping...

A University of Miami research team is studying effects of COVID-19 on medical cannabis users and is looking for survey participants. Many medical cannabis patients have compromised immune systems or suffer chronic conditions that may put them at an elevated risk from the coronavirus; so the researchers are particularly interested...

The U.S. Department of Agriculture (USDA) announced this week the approval of hemp production plans for two more states and three more Indian tribes. The states to get the green light were South Carolina and West Virginia, making them the thirteenth and fourteenth states to gain approval. The tribe plans...

AusCann Group Holdings Limited (ASX:AC8) announced on Tuesday it's ready to commence the company's first clinical evaluation, involving hard-shell capsules containing a medical cannabis based formulation. The firm says it intends conducting a randomised, open-label, cross-over Phase I bioavailability study trial with healthy volunteers evaluating the pharmacokinetics* of its hard-shell...

Bod Australia Ltd (ASX: BDA) has announced it has partnered with vitamin and skincare giant Swisse Wellness to launch a bunch of hemp-based products for the Australian market. Details are scant on the nine products, but they include various skincare items and soft gel caps containing hemp seed oil....